BFC Planning’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-500
Closed -$6.5K – 3472
2026
Q2
$6.5K Hold
500
– – ﹤0.01% 2569
2026
Q1
$5.68K Hold
500
– – ﹤0.01% 2261
2025
Q4
$6.42K Hold
500
– – ﹤0.01% 2260
2025
Q3
$5.58K Buy
+500
New +$4.82K ﹤0.01% 2156

Other funds holding ANGO

BFC Planning's ANGO Position: Q3 2026 in Review

BFC Planning sold out of AngioDynamics (ANGO) in Q3 2026, closing a stake of 500 shares — an estimated $6.5K sold.

BFC Planning first reported a position in ANGO in Q3 2025 and held it in 4 quarters. The position peaked at $6.5K in Q2 2026. 122 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

  • BFC Planning reported no remaining AngioDynamics position as of Q3 2026 after selling out during the quarter.
  • BFC Planning sold 500 AngioDynamics shares in Q3 2026, an estimated $6.5K.
  • BFC Planning first reported a position in AngioDynamics in Q3 2025 and held it in 4 quarters.
  • BFC Planning's AngioDynamics position peaked at $6.5K in Q2 2026.
  • 122 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.